Neonatal onset multisystem inflammatory disease (NOMID): Case report
Abstract
Neonatal onset multisystem inflammatory disease is a rare autoinflammatory disorder. Clinical features include fever episodes, urticarial rash, arthralgia and arthritis, eyes and central nervous system involvement. It belongs to the group of cryopyrin-associated periodic syndromes which result from a gain-of-function mutations of the NLRP3 gene on chromosome 1p44 that encodes the cryopyrin protein. Defects lead to overproduction of inflammatory cytokines involved in the innate immune system, especially interleukin 1.
This article reports a clinical case of a 6-year-old boy, who presented with first clinical signs of the disease soon after birth. We present a diagnostic approach in a case of suspected periodic fever syndrome. It is based on exclusion of infections, primary immunodeficiencies, autoimmune and malignant disorders. For confirmation of the disease, genetic analysis is mandatory. The patient was successfuly treated with biological medications which block interleukin 1.Downloads
References
Yu JR, Leslie KS. Cryopyrin-associated periodic syndrome: an update on diagnosis and treatment response. Curr Allergy Asthma Rep 2011;11:12-20.
Feldmann J, Prieur A, Quartier P, et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondocytes. Am. J. Hum. Genet. 2002;71(1):198-203.
Toplak N. Periodični vročinski sindromi. In: Kržišnik C. Pediatrija. 1. izd. Ljubljana: DZS 2014:309-10.
Hashkes PJ, Laxer RM. Cryopyrin associated periodic syndromes: difficult to recognize, diagnose, treat. The Rheumatologist 2014;10.
Toplak N, Accetto M, Avčin T. Periodični vročinski sindromi. Slovenska pediatrija 2006;13(3):122-31.
Padeh S. Periodic fever syndromes. Peditr Clin North Am 2005;52:577-609.
McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999;97:133–44.
Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol 2009; 27:621-68.
Lierl M. Periodic fever syndromes: a diagnostic challenge for the allergist. Allergy 2007;62:1349-58.
Touitou I. Infevers. The registry of hereditary avto-inflammatory disorders mutations. Dosegljivo 2.2.2015 s spletne strani: http://fmf.igh.cnrs.fr/ISSAID/infevers/.
Levy R, Gérard L, Kuemmerle.Deschner J, Lachmann HJ, Koné-Paut I, et al. Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever registry. Ann Rheum Dis 2014; Jul 18. pii: annrheumdis-2013-204991. doi: 10.1136/annrheumdis-2013-204991. Dosegljivo 2.2.2015 s spletne strani: http://ard.bmj.com/content/early/2014/07/18/annrheumdis-2013-204991.abstract.
Sinožić D, Toplak N, Milotić I. Tumor necrosis factor receptor-associated periodic fever syndrome in a 58-year old man: caution not to discount TRAPS as a diagnosis in elder patients. J Clin Rheumatol 2011;17:325-28.
Caroli F, Pontillo A, D’Osualdo A, Travan L, Ceccherini I, Crovella S, et al. Clinical and genetic characterization of Italian patients affected by CINCA syndrome. Rheumatology 2007;46:473-8.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
